Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands

Gene Therapy

Volumn 13, Issue 1, 2006, Pages 29-39

  Aldrich, W A ^a,b   Ren, C ^c   White, A F ^c   Zhou, S Z ^d   Kumar, S ^c   Jenkins, C B ^a,b   Shaw, D R ^a,b   Strong, T V ^a,b   Triozzi, P L ^a,b   Ponnazhagan, S ^b,c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Avigen Inc   (United States)

Author keywords

Adeno associated virus; Carcinoembryonic antigen; Dendritic cell; Self complementary genome

Indexed keywords

CAPSID PROTEIN; CARCINOEMBRYONIC ANTIGEN; CD40 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIGAND; LYMPHOCYTE ANTIBODY; LYMPHOCYTE SURFACE MARKER; OLIGODEOXYNUCLEOTIDE; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL CULTURE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CROSS REACTION; CULTURE MEDIUM; DENDRITIC CELL; DOWN REGULATION; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENETIC CODE; GENETIC COMPLEMENTATION; GENETIC TRANSDUCTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEROTYPE; STEM CELL; TRANSCRIPTION INITIATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS RECOMBINANT;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGENS, CD40; BONE MARROW CELLS; CARCINOEMBRYONIC ANTIGEN; CELL LINE; CPG ISLANDS; DENDRITIC CELLS; DEPENDOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 6; MIRIDAE; PARVOVIRUS;

EID: 29244438789     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302601     Document Type: Article

References (39)

1. Buning H, Nicklin SA, Perabo L, Hallek M, Baker AH. AAV-based gene transfer. Curr Opin Mol Ther 2003; 5: 367-375.
2. Flotte TR. Gene therapy progress and prospects: Recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2004; 11: 805-810.
3. Stilwell JL, Samulski RJ. Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 2003; 34: 148-150.
4. Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004; 15: 93-128.
5. Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-261.
6. Moss RB, Rodman D, Spencer LT, Aitken ML, Zeitlin PL, Waltz D et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 2004; 125: 509-521.
7. Haigwood NL, Montefiori DC, Sutton WF, McClure J, Watson AJ, Voss G et al. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J Virol 2004; 78: 5983-5995.
8. Johnson PR, Schnepp BC, Connell MJ, Rohne D, Robinson S, Krivulka GR et al. Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques. J Virol 2005; 79: 955-965.
9. Ponnazhagan S. Adeno-associated virus vectors for genetic immunization. J Immunol Res 2002; 26: 247-253.
10. Ponnazhagan S, Mahendra G, Lima J, Aldrich WA, Jenkins CB, Ren C et al. Augmentation of anti-tumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvants. Hum Gene Ther 2004; 15: 856-864.
11. Banchereau J, Steinman RM. Dendritic cells and the control of the immunity. Nature 1998; 392: 245-252.
12. Ponnazhagan S, Mahendra G, Curiel DT, Shaw DR. Adeno-associated virus-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy. J Virol 2001; 75: 9493-9501.
13. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: Mapping the way. Nat Med 2004; 10: 475-480.
14. Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212-4223.
15. Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM. Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000; 1: 323-329.
16. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302-317.
17. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.
18. Louboutin JP, Wang L, Wilson JM. Gene transfer into skeletal muscle using novel AAV serotypes. J Gene Med 2005; 7: 442-451.
19. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
20. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248-1254.
21. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111.
22. Lima J, Jenkins C, Guerrero A, Triozzi PL, Shaw DR, Strong TV. A DNA vaccine encoding genetic fusions of carcino-embryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). Vaccine 2005; 23: 1273-1283.
23. O'Toole PJ, Inoue T, Emerson L, Morrison IE, Mackie AR, Cherry RJ. Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization. J Biol Chem 2003; 278: 45770-45776.
24. Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE et al. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 1994; 54: 1164-1168.
25. Banchereau JF, Briere C, Caux J, Davoust S, Lebecque YJ, Liu B et al. Immunobiology of dendritic cells. Annu Rev Imunol 2000; 18: 767-811.
26. Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines. Cell 2001; 106: 255-258.
27. Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 2002; 109: 1519-1526.
28. Zhou Y, Bosch ML, Salgaller ML. Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J Immunother 2002; 25: 289-303.
29. Roth MD, Cheng Q, Harui A, Basak SK, Mitani K, Low TA et al. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. J Immunol 2002; 169: 4651-4656.
30. Sarukhan A, Camugli S, Gjata B, von Boehmer H, Danos O, Jooss K. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269-277.
31. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
32. Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828-834.
33. Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001; 75: 6615-6624.
34. Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000; 74: 2777-2785.
35. Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol 2001; 75: 4080-4090.
36. Sanlioglu S, Monick MM, Luleci G, Hunninghake GW, Engelhardt JF. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 2001; 1: 137-147.
37. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004; 101: 16606-16611.
38. Ponnazhagan S, Mahendra G, Kumar S, Shaw DR, Meleth S, Stockardt R et al. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: Long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. Cancer Res 2004; 64: 1781-1787.
39. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.